What's happening
This bill requires a study of New York Medicaid reimbursement rates for durable medical equipment, orthotics, and prosthetics to assess adequacy and access.
Why it matters
Evaluates whether current Medicaid reimbursement rates for durable medical equipment, orthotics, and prosthetics are sufficient to ensure patient access. , which may highlight if low rates are limiting availability or quality of these essential health devices for New Yorkers.
Examines disparities and barriers to access, including racial, socioeconomic, geographic, and workforce factors. , potentially uncovering inequities that affect who receives timely and effective care, and where access gaps exist.
Requires an in-depth review of payment methodologies and the inclusion of stakeholder input. , which could lead to recommendations for policy changes that align Medicaid payments more closely with actual costs, prevailing Medicare rates, or evolving technology.
Assesses the broader impacts such as cost savings associated with Medicaid recipients returning to work after receiving orthotics or prosthetics. , suggesting the study could inform not just health outcomes but also economic and workforce policy decisions.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Study Prosthetic Payment Rates
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to ways and means
- Returned to assembly
- Repassed senate
- Amended on third reading 7023a
- Vote reconsidered - restored to third reading
- Returned to senate
- Recalled from assembly
- Referred to ways and means
- Delivered to assembly
- Passed senateVote 63–0
- Advanced to third reading
- 2nd report cal.
Show 3 earlier actions
- 1st report cal.118
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Study Prosthetics Payment Rates
Assembly Floor Calendar · Sponsor Aileen Gunther
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7023--A Cal. No. 118
2021-2022 Regular Sessions
IN SENATE
May 24, 2021
Introduced by Sens. MANNION, KENNEDY, REICHLIN-MELNICK, SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote reconsidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading
AN ACT directing the commissioner of health to conduct a study on the rates of reimbursement made through the New York state Medicaid durable medical equipment, orthotics, prosthetics and supplies program for rate adequacy and patient access; and providing for the repeal of such provisions upon expiration thereof
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The commissioner of health shall conduct a study to review the rates of reimbursement made through the New York state Medicaid durable medical equipment, orthotics, prosthetics and supplies program for rate adequacy and patient access, including those made under all capitated and contract coverage models. Such review shall include:
(a) an analysis of rules, regulations and policies for orthotics and prosthetics service/device provisions under the New York Medicaid program, including all contracted and capitated models;
(b) a comprehensive assessment of the existing methodology used to determine payment or nonpayment for prosthetic and orthotic care including but not limited to:
(i) all orthotic and prosthetic codes on the current Medicaid fee schedule, including but not limited to a comparison of prevailing Medicare fee schedule amounts and New York Medicaid amounts;
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11559-03-2
(ii) codes on the Medicare fee schedule but not included on the New York state Medicaid durable medical equipment, orthotics, prosthetics and supplies program fee schedule;
(iii) recommendations for changing reimbursement methodologies. Recommendations under this subparagraph shall be consistent with federal law and shall include recommendations for appropriate changes in state law and regulations. Such recommendations shall consider appropriate payment methodologies for codes not included on the Medicaid fee schedule;
(c) assessment of barriers to timely service provision as well as racial and socioeconomic disparities in access including, but not limited to, travel time required, geographic variability, access to and cost of technology;
(d) the workforce needed to provide orthotic and prosthetic services in the next five years to eligible children and adults, disaggregated by county;
(e) opportunities for stakeholder input on current rate methodologies; and
(f) assessment of cost savings associated with percentage of Medicaid population returning to work after orthotic and/or prosthetic provision.
§ 2. Within one year after the effective date of this act, the commissioner of health shall submit a report of the findings and recommendations pursuant to this act to the governor, the temporary president of the senate, the minority leader of the senate, the speaker of the assembly, the minority leader of the assembly, and the chairs and ranking members of the senate and assembly committees on health and shall post such report on the department of health's website.
§ 3. The commissioner of health shall be authorized to promulgate rules and regulations to provide for the orderly effectuation of the provisions of this act.
§ 4. This act shall take effect immediately and shall expire and be deemed repealed upon the submission of the report required pursuant to section two of this act.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act directing the commissioner of health to conduct a study on the rates of reimbursement made through the New York state Medicaid durable medical equipment, orthotics, prosthetics and supplies program for rate adequacy and patient access; and providing for the repeal of such provisions upon expiration thereof
Purpose
To conduct a study to review the rates of reimbursement made through the the rates of reimbursement made through the New York state Medicaid durable medical equipment, orthotics, prosthetics and supplies program for rate adequacy and patient access.
Summary of provisions
Section 1. Requires the commissioner of health to conduct a study to review the rates of reimbursement made through the New York state Medi- caid durable equipment, orthotics, prosthetics and supplies program for rate adequacy and patient access including those made under all capita- tion and contract coverage models. Establishes the components of the review.
Read the full memo (652 words)
Section 2. Establishes that one year after the effective date of this act, the commissioner of health must submit a report of the findings and recommendations to the governor, temporary president of the senate, the speaker of the assembly and the chairs of the senate and assembly committees on health. Establishes that the report must be posted on the department of health's website.
Section 3. Authorizes the commissioner of health to promulgate rules and regulations.
Section 4. Establishes the effective date and expiration of this act upon the submission of the report.
Justification
New York residents who are enrolled in the NY Medicaid program and are in need of access to orthotic and prosthetic (O&P) care have been nega- tively impacted by the stagnant NY Medicaid O&P reimbursement rates. On average, NY Medicaid currently reimburses 67% of the prevailing Medicare reimbursement, which is lower than the 75% national average.
The current law authorizes the Medicaid program to reimburse "orthotic and prosthetic devices" at a rate that must not exceed the lower price in the NY Medicaid DME Services Fee Schedule or the usual customary price charged to the general public, and the reimbursement of items with no price listed in the fee schedule must not exceed the lower of th acquisition cost, plus 50% or the usually customary price charged to the general public.
Reimbursement for the skilled services and devices needed by certified orthotists and prosthetists for their patients is facilitated using L-codes, which are billed at delivery and include the device, its fabri- cation and ongoing follow-up care. However, the NY Medicaid reimburse- ment for these devices have remained stagnant since 1987, failing to keep up with the Medicare reimbursement rates.
This means there are an estimated 80 codes for orthotic and prosthetic technologies that are not currently listed on the NY Medicaid fee sched- ule and such technologies are not available for individuals who need them. Individuals looking for devices not on the medicaid fee schedule must pay out-of-pocket, which can often be extraordinarily burdensome. Additionally, the stagnant reimbursement rates with inflation have led to the closure of about 30 O&P practices across the State, leaving Medi- caid enrollees with very limited options and no choice but to utilize used devices or continue using ill-fitting devices, which is a safety hazard.
This legislation requires the commissioner of health to conduct a study to review the rates of reimbursement made through the New York state Medicaid durable equipment, orthotics, prosthetics and supplies program for rate adequacy and patient access including those made under all capitation and contract coverage models. Vulnerable populations across the State who are suffering from debilitating injuries, disease or birth defects deserve to be treated as equals. The State must investigate and ensure parity which begins with an adequacy review of reimbursement rates for orthotics and prosthetics.
Fiscal implications
TBD
Effective date
Immediately and shall expire and be deemed repealed upon the submission of the report required pursuant to section two of this act.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.